Company / Profit Margin
Crinetics Pharmaceuticals, Inc. Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-6046.2%
FY2025
5-year range
-28720.7% / -3460.4%
FY2021-FY2025
Trend
+78.9%
vs FY2024
Sector context
#142 of 146
Health Care
What the data says
Among 146 Health Care companies, Crinetics Pharmaceuticals, Inc. is in the bottom 3% for profit margin. Profit Margin has fluctuated over the past 8 years, ranging from -28720.7% in FY2024 to -447.8% in FY2019.
Based on SEC 10-K filings.
-6046.2% in FY2025 with a 5-year CAGR of -4929.5%.
Declined from -3460.4% to -6046.2% over the past 3 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -2585.8pp
- 5-Year Change
- -4929.5pp
- 10-Year Change
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 146This company -6046.2% Sector average -796.3%
▼
-659.3% below sector average
Key checks
Key Insights
- In FY2025, profit margin increased 78.9% year-over-year.
- Currently 5249.9pp below the Health Care sector average.
- Peak profit margin was recorded in FY2019.
- Lowest profit margin in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -6046.2% | +78.9% |
| FY2024 | -28720.7% | - |
| FY2023 | - | - |
| FY2022 | -3460.4% | +65.3% |
| FY2021 | -9985.3% | -794.1% |
| FY2020 | -1116.8% | -149.4% |
| FY2019 | -447.8% | +56.2% |
| FY2018 | -1021.9% | - |
| FY2017 | - | - |
| FY2016 | -1021.9% | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026